NexPoint Event Driven A (HHCAX)
13.88
0.00 (0.00%)
USD |
Jun 29 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 2.16% | 23.34M | 0.00% | 168.0% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| 4.812M | -24.36% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund seeks to primarily invest in equity, debt, and/or derivative securities of companies that the Adviser expects to benefit from an event catalyst. The fund may invest significantly in the common stock of and other interests (e.g., warrants) in special purpose acquisition companies or similar special purpose entities that pool funds to seek potential acquisition opportunities (collectively, “SPACs”). It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | HHCZX |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Nontraditional Equity |
| Broad Category | Equity |
| Category Name | Long-Short Equity |
| Category Index | MSCI ACWI NR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | Highland Funds |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| James Dondero | 4.18 yrs |
| Scott Johnson | 0.07 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
28
4.812M
-496.54M
Category Low
548.63M
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2022
Performance Versus Category
As of June 29, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of June 29, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Berkeley Lights Inc Ordinary Shares | 8.61% | 4.89 | 1.24% |
|
Samsung BioLogics Co Ltd
|
7.88% | -- | -- |
| NextCure Inc | 7.86% | 4.77 | -1.45% |
| Convey Health Solutions Holdings Inc Ordinary Shares | 7.44% | 10.38 | -0.19% |
| Dreyfus Treasury Obligations Csh Mgt Ins | 4.96% | 1.00 | 0.00% |
| Natera Inc | 4.19% | 36.46 | -1.13% |
| Sorrento Therapeutics Inc | 4.10% | 2.02 | 1.51% |
| Singular Genomics Systems Inc | 4.08% | 3.84 | 1.86% |
| AbbVie Inc | 4.05% | 153.45 | -0.45% |
| uniQure NV | 4.01% | 18.61 | 0.76% |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund seeks to primarily invest in equity, debt, and/or derivative securities of companies that the Adviser expects to benefit from an event catalyst. The fund may invest significantly in the common stock of and other interests (e.g., warrants) in special purpose acquisition companies or similar special purpose entities that pool funds to seek potential acquisition opportunities (collectively, “SPACs”). It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | HHCZX |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Nontraditional Equity |
| Broad Category | Equity |
| Category Name | Long-Short Equity |
| Category Index | MSCI ACWI NR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | Highland Funds |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| James Dondero | 4.18 yrs |
| Scott Johnson | 0.07 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (6-29-22) | 0.00% |
| 30-Day SEC Yield (6-22-22) | Upgrade |
| 7-Day SEC Yield (6-29-22) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of September 30, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 5/5/2008 |
| Last Annual Report Date | 6/30/2021 |
| Last Prospectus Date | 1/16/2022 |
| Share Classes | |
| HHCCX | C |
| HHCZX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |